Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females
| dc.contributor.author | Tariq, Saba | |
| dc.contributor.author | Tariq, Sundus | |
| dc.contributor.author | Abualhamael, Shahad Abduljalil | |
| dc.contributor.author | Baig, Mukhtiar | |
| dc.contributor.author | Malik, Ahmad Azam | |
| dc.contributor.author | Shahzad, Muhammad | |
| dc.date.accessioned | 2023-11-28T11:41:07Z | |
| dc.date.available | 2023-11-28T11:41:07Z | |
| dc.date.issued | 2023 | |
| dc.department | İstanbul Medipol Üniversitesi, Rektörlük, Sağlık Bilim ve Teknolojileri Araştırma Enstitüsü | |
| dc.department | İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Fizyoloji Ana Bilim Dalı | |
| dc.description.abstract | ObjectivesThe present study investigated osteoprotegerin (OPG) genetic polymorphisms and their influence on the therapeutic response to ibandronate in postmenopausal osteoporotic females.MethodsThis case-control study included 135 postmenopausal females (89 osteoporotic females and 46 non-osteoporotic females). Each osteoporotic patient received a monthly 150 mg ibandronate tablet for six months, and blood samples were taken before and after treatment. Bone mineral density (BMD) was measured using DEXA Scan. Three SNPs (A163G, T245G, and G1181C) of the OPG gene were selected for analysis.ResultsSerum OPG levels were significantly lower in osteoporotic subjects than in the control group. The percentage changes in OPG levels in the osteoporotic group before and after treatment with ibandronate were significant (p < .001). After six months of therapy with ibandronate, the percentage changes in OPG levels with AA, TT, TC, GC, and GG genotypes were significant. Following six months of ibandronate treatment, the AA genotype of rs3134069, TT, TC genotypes of rs3102735, GG, and GC genotypes of rs2073618 SNP showed a significant increase in OPG levels. Age, BMI, and GC polymorphism (rs2073618 (G/C) G1181C) were inversely associated with low BMD. Adjusted odds ratios (OR) showed that BMI, GC, GG polymorphism (rs2073618 (G/C) G1181C) and TC polymorphism (rs3102735 (T/C) A163G) were inversely associated with low BMD.ConclusionThe inverse association of rs2073618 and rs3102735 with low BMD indicates the protective role of these SNPs in our population. More research is needed to replicate these results in another cohort and to determine the molecular processes by which such SNPs may influence BMD. | |
| dc.description.sponsorship | WCO-IOF-ESCEO 2022 | en_US |
| dc.identifier.citation | Tariq, S., Tariq, S., Abualhamael, S. A., Baig, M., Malik, A. A. ve Shahzad, M. (2023). Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females. PLoS ONE, 18(9). https://dx.doi.org/10.1371/journal.pone.0291959 | |
| dc.identifier.doi | 10.1371/journal.pone.0291959 | |
| dc.identifier.issn | 1932-6203 | |
| dc.identifier.issue | 9 | |
| dc.identifier.pmid | 37751449 | |
| dc.identifier.scopus | 2-s2.0-85172687760 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://dx.doi.org/10.1371/journal.pone.0291959 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/11886 | |
| dc.identifier.volume | 18 | |
| dc.identifier.wos | 001079916200003 | en_US |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Tariq, Sundus | |
| dc.language.iso | en | |
| dc.publisher | Public Library of Science | |
| dc.relation.ispartof | PLoS ONE | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | Attribution 4.0 International | * |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Osteoporotic Females | |
| dc.subject | Genetic Polymorphisms | |
| dc.subject | Ibandronate | |
| dc.title | Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females | |
| dc.type | Article |
